Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:3988
SEHK:3988Banks

The Bull Case For Bank of China (SEHK:3988) Could Change Following Higher 2025 Dividend Proposal

Bank of China Limited reported its full-year 2025 results, with net interest income of CNY 440.71 billion and net income of CNY 243.02 billion, and the board recommended a 2025 final dividend of CNY 1.169 per 10 shares, subject to shareholder approval. The bank also confirmed Ms. Huang Xueling’s appointment as Executive Vice President in late March 2026, highlighting ongoing leadership renewal alongside a higher proposed cash return to shareholders. We’ll now examine how the higher proposed...
ASX:GDG
ASX:GDGInsurance

A Look At Generation Development Group’s Valuation After Its 90% Half Year Earnings Collapse

Why the earnings collapse matters for Generation Development Group Generation Development Group (ASX:GDG) shocked investors with half-year results showing net income down more than 90%, raising fresh questions about profit resilience, earnings volatility, and exposure to regulatory shifts. This sharp earnings contraction arrived alongside underlying growth in funds under management and core segments, prompting investors to reassess how much near term profit pressure should influence views on...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Should Guardant Health’s (GH) Role in ENHERTU’s Japan Approval Require Action From Investors?

In late March 2026, Guardant Health announced that its InfinityAI real-world evidence platform was used alongside clinical trial data to support Japan’s approval of Daiichi Sankyo’s ENHERTU for treating HER2-positive advanced or recurrent solid cancers refractory or intolerant to standard therapies. This use of InfinityAI highlights how Guardant’s clinicogenomic data and artificial intelligence can help regulators assess outcomes in genomic subpopulations that are difficult to enroll in...
ASX:PNI
ASX:PNICapital Markets

Does Pinnacle (ASX:PNI) Using Expanded Debt Capacity Signal Evolving Discipline in Growth Financing?

Pinnacle Investment Management Group recently extended and increased its debt facility with Commonwealth Bank of Australia from A$100,000,000 to A$250,000,000, while keeping pricing terms unchanged. This larger facility, supported by Pinnacle’s earnings profile, gives the group more balance sheet flexibility to finance future funds management growth initiatives. We’ll now examine how this expanded Commonwealth Bank facility shapes Pinnacle’s investment narrative, particularly around capital...
TSE:6702
TSE:6702IT

Assessing Fujitsu (TSE:6702) Valuation After New Quantum Computing Breakthrough

Quantum computing breakthrough puts Fujitsu (TSE:6702) in focus Attention on Fujitsu (TSE:6702) has picked up after the company and the Center for Quantum Information and Quantum Biology at The University of Osaka unveiled a quantum computing technology aimed at practical chemical material design. The partners combined version 3 of Fujitsu’s STAR architecture with a new molecular model optimization technique to cut computational resource requirements for energy calculations used in material...
ASX:MFF
ASX:MFFCapital Markets

Did Chris Mackay’s Latest On‑Market Buying Just Deepen MFF Capital Investments’ (ASX:MFF) Governance Alignment?

MFF Capital Investments Ltd. recently disclosed that director Chris Mackay acquired 103,445 fully paid ordinary shares on-market on 30 and 31 March 2026, lifting his direct and indirect holdings to 126,954,991 shares. This additional insider buying strengthens the alignment between Mackay and other shareholders, as a larger portion of the investment vehicle is now held by a key decision-maker. We will now consider how Mackay’s increased shareholding informs MFF Capital Investments’ broader...
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

Why Celcuity (CELC) Is Up 5.5% After Reporting Wider 2025 Losses From Ongoing R&D Spending

Celcuity Inc. recently reported fourth-quarter 2025 results showing a net loss of US$50.97 million, with basic loss per share from continuing operations of US$0.97, and a full-year 2025 net loss of US$177.04 million, or US$3.79 per share, both higher than the prior year. The sharp year-on-year increase in reported net loss highlights the cost of Celcuity’s ongoing development and commercialization efforts as it remains a pre-revenue, clinical-stage biotechnology company. With losses widening...
NasdaqGS:CWST
NasdaqGS:CWSTCommercial Services

A Look At Casella Waste Systems (CWST) Valuation After Recent Mixed Share Price Performance

Casella Waste Systems stock moves after recent share performance Casella Waste Systems (CWST) has caught investor attention after a mixed recent run, with the stock up around 10% over the past week but showing declines over the month and past 3 months. See our latest analysis for Casella Waste Systems. At a share price of $86.23, Casella’s recent 10% 7 day share price return contrasts with weaker 1 month and year to date share price returns. The 1 year total shareholder return of 17.11% and 5...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Why Rhythm Pharmaceuticals (RYTM) Is Up 12.6% After EU IMCIVREE Expansion Boost and Board Refresh – And What's Next

Rhythm Pharmaceuticals recently received a positive opinion from the European Medicines Agency’s CHMP to expand IMCIVREE’s authorization to acquired hypothalamic obesity, and appointed veteran life sciences leader Kim Popovits to its Board, succeeding Ed Mathers. This combination of potential European label expansion for IMCIVREE and added commercialization expertise on the Board may meaningfully influence how Rhythm executes its rare neuroendocrine disease focus. Next, we’ll examine how the...
ASX:AUI
ASX:AUICapital Markets

3 ASX Dividend Stocks Yielding Up To 7.2%

As the Australian market rebounds with a modest 0.2% rise following the Easter long weekend, optimism is brewing amid potential geopolitical resolutions and positive movements in global indices. In this environment, dividend stocks stand out as a compelling option for investors seeking steady income streams, particularly when market volatility is influenced by international tensions and economic data releases.
ASX:GYG
ASX:GYGHospitality

ASX Growth Stocks With High Insider Ownership And Up To 38% Earnings Growth

The Australian stock market is showing signs of resilience, with a modest rise anticipated following the Easter long weekend, buoyed by positive movements in U.S. indices and hopes for a potential ceasefire in international tensions. In this environment of cautious optimism, growth companies with high insider ownership can be particularly appealing to investors seeking alignment between company leadership and shareholder interests.
ASX:WTC
ASX:WTCSoftware

ASX Value Stocks Trading Below Estimated Worth In April 2026

As the Australian market gears up for a positive start following the Easter long weekend, investors are closely watching global developments, particularly the potential U.S.-Iran ceasefire that could influence market sentiment. In this environment of cautious optimism, identifying undervalued stocks on the ASX can be key to capitalizing on potential growth opportunities, as these stocks may offer value relative to their current trading prices amidst broader economic uncertainties.
ASX:BKI
ASX:BKICapital Markets

Discovering Three Promising Australian Stocks with Solid Potential

As the Australian stock market gears up for a modest rise following the Easter long weekend, buoyed by positive movements in major U.S. indices and potential geopolitical resolutions, investors are keenly observing small-cap stocks for opportunities amidst broader market optimism. In this environment, identifying stocks with strong fundamentals and growth potential becomes crucial as they can offer promising prospects even in fluctuating conditions.
ASX:EHL
ASX:EHLTrade Distributors

ASX Penny Stocks Spotlight: Emeco Holdings Among 3 Top Picks

The Australian market is showing signs of optimism, with a slight uptick in shares following the Easter long weekend, despite ongoing geopolitical tensions. Penny stocks, while an older term, continue to represent opportunities for growth by focusing on smaller or newer companies that offer potential value at lower price points. By identifying those with strong balance sheets and solid fundamentals, investors can uncover hidden gems that may provide both stability and potential upside in...
NYSE:LPX
NYSE:LPXForestry

Is It Too Late To Reassess Louisiana Pacific (LPX) After Recent Share Price Swings?

If you are wondering whether Louisiana-Pacific at around US$72 a share is offering good value or is already pricing in a lot of expectations, this article will help you frame that question using several valuation lenses. The stock has been choppy recently, with a 2.6% gain over the last 7 days, a 7.2% decline over 30 days, and year-to-date returns showing an 11.7% decline, while the 3-year and 5-year returns sit at 35.5% and 22.4% respectively. Recent attention on Louisiana-Pacific has...
NYSE:IBP
NYSE:IBPConsumer Durables

How Investors Are Reacting To IBP’s Earnings Beat, Weather-Hit Sales And Bigger Buyback Plan

Installed Building Products recently reported fourth-quarter earnings per share of US$3.24, beating expectations while revealing a 9% sales decline in its residential segment and announcing a new US$500 million share repurchase program alongside higher dividends. Management also reduced near-term revenue guidance and cited severe winter weather as a key factor pressuring residential insulation demand, even as commercial activity and acquisition efforts provided a partial offset. Next, we’ll...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

Is It Time To Reassess QuidelOrtho (QDEL) After The Recent Share Price Slump?

If you are wondering whether QuidelOrtho's current share price reflects its underlying value, this article walks through the key numbers that investors tend to focus on before making a decision. QuidelOrtho last closed at US$15.88, with returns of 4.1% over the past week, a 23.8% decline over the past month, and year to date and 1 year returns of 44.8% and 44.0% declines respectively. The 3 year and 5 year returns sit at 82.5% and 87.5% declines. These moves come as investors reassess the...
NasdaqGS:DOX
NasdaqGS:DOXIT

Did Amdocs’ (DOX) aOS Launch and Carrier Deals Just Redefine Its Telecom Software Ambitions?

Amdocs recently extended its long-term relationship with T-Mobile under a new multi-year agreement covering managed services, software development, and AI innovation, while also expanding its engagement with Vodafone Germany, adding two western European clients, completing the Matrixx Software acquisition, and unveiling its telecom-focused aOS agentic operating system. Together, these moves point to Amdocs deepening its role at large carriers and broadening its telecom software capabilities...
CNSX:CXXI
CNSX:CXXIPharmaceuticals

3 TSX Penny Stocks With Market Caps Under CA$300M To Consider

By the end of last week, markets rebounded from the lows, and the S&P 500 and Canadian TSX indexes were positive for the week, after negative returns in March. As uncertainty continues to linger, particularly around oil prices, investors are exploring diverse opportunities to navigate these fluctuating conditions. Penny stocks—though an older term—still capture attention as they represent smaller or newer companies that may offer growth potential at lower price points. In this article, we...